Influencing factors and clinical significance of coagulation intensity of direct antiglobulin test antibody
-
摘要: 目的:探讨直接抗人球蛋白试验(DAT)抗体凝集强度的影响因素及其临床意义。方法:采用低离子抗人球蛋白卡对182例DAT阳性患者标本作凝集强度检测和抗体及补体类型鉴定,并对DAT阳性不同凝集强度的患者进行输血后有效率对比分析。结果:182例DAT阳性患者中自身免疫性溶血性贫血、系统性红斑狼疮凝集强度3~4+分别为85.7%和76.2%,占比较其他疾病高;随着输血次数的增加DAT阳性患者抗体凝集强度也明显增强;DAT阳性重度贫血患者中抗体凝集强度3~4+占87.5%,而轻度贫血患者中只占13.5%;单纯C3d DAT阳性凝集强度3~4+为9.1%,而复合型IgG+IgM+C3d+C3c DAT阳性凝集强度3~4+占比为71.4%。且DAT阳性的不同凝集强度患者之间输血前后血红蛋白比较,凝集强度为3~4+组增长水平明显低于1+组,差异有统计学意义(P<0.01).结论:DAT阳性患者的凝集强度与疾病类型、输血次数、贫血程度和抗体及补体类型相关,且DAT阳性患者治疗效果与抗体及补体凝集强度具有一定的关系。因此DAT阳性患者抗体及补体凝集强度对DAT贫血患者的输血治疗效果和判断预后具有重要的参考意义。Abstract: Objective: To explore the influencing factors and clinical significance of the direct antiglobulin test(DAT) positive agglutination intensity.Methods: A total of 182 cases of DAT-positive specimens were tested for antibody strength and antibody and complement typing tests by using microcolumn gel anti-human globulin card, and the efficiency of DAT positive patients with different antibody strengths was compared after transfusion.Results: The autoimmune hemolytic anemia and systemic lupus erythematosus agglutination intensity of 3 to 4+in 182 DAT-positive patients were 85.7% and 76.2%, respectively, which was higher than other diseases. With the increase of the number of blood transfusions, the agglutination intensity of DAT-positive patients also increased significantly; the agglutination intensity of DAT-positive patients with severe anemia was 3-4+accounting for 87.5%, while the patients with mild anemia only accounted for 13.5%. Simple C3 d DAT positive agglutination intensity 3-4+was 9.1%, while composite IgG+IgM+C3 d+C3 c DAT positive agglutination intensity 3-4+accounted for 71.4%. The comparison of hemoglobin value(Hb) before and after blood transfusion among DAT-positive patients with different agglutination intensities found that the increase in agglutination intensities between 3 and 4+groups was significantly lower than that in the 1+group, the difference was statistically significant(P<0.01).Conclusion: The intensity of agglutination in DAT-positive patients may be correlated with the type of disease, the number of blood transfusions, the degree of anemia, and the type of antibodies and complement. And the therapeutic effect of DAT positive patients may have a certain relationship with the strength of antibodies. Therefore, the intensity of antibody agglutination in DAT-positive patients may have important reference significance for the treatment effect and prognosis of anemia patients.
-
Key words:
- direct anti-human globulin test /
- antibody type /
- transfusion effect
-
[1] 蔡巧莲,魏寿忠,林桂花.微柱凝胶直接抗人球蛋白试验阳性分型与临床疾病相关性探讨[J].临床血液学杂志,2018,31(4):268-270.
[2] 曹廷卉,王广杰,红细胞输注的疗效观察与输注无效的探讨[J].中国输血杂志,2015,28(10):1241-1243.
[3] Ricci F,Tedeschi A,Vismara E,et al.Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia[J].Clin Lymphoma Myeloma Leuk,2013,13(4):441-446.
[4] 阳福桂,刘芳,戚志萍,李宁.直接抗人球蛋白试验在临床贫血及输血患者中的应用[J].临床输血与检验,2015,17(6):498-500.
[5] 刘志刚,蔡晓红,邹纬,等.红细胞自身抗体阳性患者输血疗效分析[J].中国输血杂志,2015,28(8):940-942.
[6] 梅城,阳福桂,覃婉元,等.122例直接抗人球蛋白试验阳性病例分析[J].免疫学杂志,2017,33(5):433-436.
[7] Felder KM,Hoelzle K,Heinritzi K,et al.Antibodies to actin in autoimmune haemolytic anaemia[J].BMC Vet Res,2010,6:18.
[8] 丁琴丽,皱丽萍,赖密.直接抗人球蛋白试验阳性患者的输血疗效评估[J].当代医学,2018,24(12):73-75.
[9] Dierickx D,Kentos A,Delannoy A.The role of rituximab in adults with warm antibody autoimmune hemolytic anemia[J].Blood,2015,125(21):3223-3229.
[10] Chaudhary RK,Das SS.Autoimmune hemolytic anemia:From lab to bedside[J].Asian J Transfus Sci,2014,8(1):5-12.
计量
- 文章访问数: 273
- PDF下载数: 538
- 施引文献: 0